Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record.

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

Skinner, Michael H., Kuan, Han‐Yi, Pan, Alan, Sathirakul, Korbtham, Knadler, Mary Pat, Gonzales, Celedon R., Yeo, Kwee Poo, Reddy, Shobha, Lim, Maggie, Ayan‐Oshodi, Mosun, Wise, Stephen D. · 2003 · Clinical Pharmacology & Therapeutics

Abstract

Background and Objectives: Duloxetine, a potent dual reuptake inhibitor of serotonin and norepinephrine currently undergoing clinical investigation for treatment of depression and stress urinary incontinence, has the potential to act as both a substrate and an inhibitor of cytochrome P4502D6 (CYP2D6). Our objectives were to determine the effect of duloxetine on the pharmacokinetics of desipramine, a tricyclic antidepressant metabolized by CYP2D6 (study 1), and the effect of paroxetine, a potent CYP2D6 inhibitor, on duloxetine pharmacokinetics (study 2). Methods: Subjects were healthy men and women between 21 and 63 years old. All subjects were genotypically CYP2D6 extensive metabolizers. In study 1, 50 mg of desipramine was administered as a single dose alone and in the presence of steady‐state duloxetine 60 mg twice daily. In study 2, steady‐state pharmacokinetics of duloxetine 40 mg once daily were determined in the presence and absence of steady‐state paroxetine 20 mg once daily. Results: Duloxetine increased the maximum plasma concentration of desipramine 1.7‐fold and the area under the concentration‐time curve 2.9‐fold. Paroxetine increased the maximum plasma concentration of duloxetine and the area under the concentration‐time curve at steady state 1.6‐fold. Reports of adverse events were similar whether duloxetine was administered alone or in combination with desipramine or paroxetine. Conclusion: Duloxetine 60 mg twice daily is a moderately potent CYP2D6 inhibitor, intermediate between paroxetine and sertraline. The potent CYP2D6 inhibitor paroxetine has a moderate effect on duloxetine concentrations. The results of these 2 studies suggest that caution should be used when CYP2D6 substrates and inhibitors are coadministered with duloxetine. Clinical Pharmacology & Therapeutics (2003) 73, 170–177; doi: 10.1067/mcp.2003.28

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1067/mcp.2003.28

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Skinner, M. H., Kuan, H., Pan, A., Sathirakul, K., Knadler, M. P., Gonzales, C. R., Yeo, K. P., Reddy, S., Lim, M., Ayan‐Oshodi, M., & Wise, S. D.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2003-03
Volume
73
Issue
3
Pages
170-177
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2148875560
Cited by
195
References
0
FWCI
8.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.